Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density

BACKGROUND AND OBJECTIVE: Abaloparatide, an anabolic osteoporosis treatment administered by subcutaneous (SC) injection, increases bone mineral density (BMD) and reduces fracture risk in postmenopausal women with osteoporosis. The abaloparatide-solid Microstructured Transdermal System [abaloparatide...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Drug Investig
Autors principals: Miller, Paul D., Troy, Steven, Weiss, Richard J., Annett, Miriam, Schense, Jason, Williams, Setareh A., Mitlak, Bruce
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2021
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7946681/
https://ncbi.nlm.nih.gov/pubmed/33638863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-021-01008-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars